These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 4273582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
    Cunningham-Rundles S, Filippa DA, Braun DW, Antonelli P, Ashikari H.
    J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F, Genetel N, Rioux-Leclercq N, Bansard JY, Levêque J, Guillé F, Patard JJ, Lesimple T, Catros-Quemener V.
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996 Jun; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

  • 12. [Immune surveillance in neoplasms].
    Schneeweiss U.
    Z Exp Chir; 1974 Jun; 7(4):204-15. PubMed ID: 4440030
    [No Abstract] [Full Text] [Related]

  • 13. Immunomorphologic changes in regional lymph nodes associated with cancer.
    Brynes RK, Hunter RL, Vellios F.
    Arch Pathol Lab Med; 1983 May; 107(5):217-21. PubMed ID: 6687668
    [Abstract] [Full Text] [Related]

  • 14. The progressive lymph node defect in cancer patients.
    Hickok DF.
    Surg Forum; 1970 May; 21():114-6. PubMed ID: 5514701
    [No Abstract] [Full Text] [Related]

  • 15. [Immunomorphology in oncology].
    Rimondi AP, Cavazzini L, Nenci I.
    Minerva Med; 1982 Apr 28; 73(18):1139-44. PubMed ID: 6979009
    [No Abstract] [Full Text] [Related]

  • 16. Host control of tumor growth.
    Ting CC, Tsai SC, Rogers MJ.
    Science; 1977 Aug 05; 197(4303):571-3. PubMed ID: 267328
    [Abstract] [Full Text] [Related]

  • 17. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M, Kinoshita K.
    J Natl Cancer Inst; 1974 Dec 05; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.